Adam Grossman became the CEO of ADMA Biologics, Inc. (NASDAQ:ADMA) in 2011. This report will, first, examine the CEO… …read more
Source:: Yahoo Finance
Newswire
- [ August 28, 2025 ] Aditxt’s (NASDAQ: ADTX) Subsidiary Adimune Highlights Its Approach to Reprogramming the Immune System Through DNA Instructions, Now with 96 Granted and 22 Pending Patents Targeting Autoimmunity Market Estimated at Over $160 Billion by 2030 Newsmakers
- [ August 27, 2025 ] Advent Technologies (NASDAQ: ADN) engages Fata Advisory to Support Business Development for Aerospace, Defense, and Commercial Markets Newsmakers
- [ August 27, 2025 ] Wellgistics Health (NASDAQ: WGRX) Introduces HubRx AI: Advancing the AI-Powered Prescription Ecosystem Healthcare
- [ August 26, 2025 ] Advent (NASDAQ: ADN) Technologies Pursuing Trailblazing Initiatives in Space Aerospace & Defense
- [ August 21, 2025 ] Advent Technologies (NASDAQ: ADN) and Global Semiconductor & Wireless Technology Company Sign Agreement for Ion Pair Membrane Development for Gas Sensing Advent Technologies Holdings, Inc. Thu, August 21, 2025 at 5:00 AM PDT 4 min read Aviation
- [ August 18, 2025 ] Advent Technologies (NASDAQ: ADN) and Stralis announce Pioneering Relationship to Advance Hydrogen Electric Flight Aerospace & Defense
- [ August 13, 2025 ] Advent Technologies (NASDAQ: ADN) Enhances License to Groundbreaking Ion Pair Technology Developed at Los Alamos National Laboratory by Acquiring Exclusivity in Marine, Aviation, and Portable Power Fields Aerospace & Defense
- [ July 29, 2025 ] Aditxt’s (NASDAQ: ADTX) Subsidiary, Pearsanta, Inc. Engages Spartan Capital as Lead Underwriter for Planned IPO Newsmakers
- [ July 29, 2025 ] Hoth Therapeutics (NASDAQ: HOTH) Announces Engagement with ICON and Expansion of Phase II Clinical Trial for HT-001 in Europe Newsmakers
- [ July 23, 2025 ] Next Super Stock: Aditxt (NASDAQ: ADTX) = “Unicorn Farm” of Billion Dollar Healthcare Opportunities & Multiple Shots on Goal for +10X CEO Interview
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.